These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7897218)

  • 1. Modulation of antibody affinity by an engineered amino acid substitution.
    Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
    J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Margolies MN
    J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single engineered amino acid substitution changes antibody fine specificity.
    Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
    J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
    J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of a model of a F(ab) complex with phenylarsonate by oligonucleotide-directed mutagenesis.
    Sompuram SR; Sharon J
    J Immunol; 1993 Mar; 150(5):1822-8. PubMed ID: 8436817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme.
    Lavoie TB; Drohan WN; Smith-Gill SJ
    J Immunol; 1992 Jan; 148(2):503-13. PubMed ID: 1729369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
    Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
    J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of anti-3-fucosyllactosamine (Le(x)) and galactosylgloboside antibodies.
    Snyder JG; Dinh Q; Morrison SL; Padlan EA; Mitchell M; Yu-Lee LY; Marcus DM
    J Immunol; 1994 Aug; 153(3):1161-70. PubMed ID: 7913110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
    Jackson JR; Sathe G; Rosenberg M; Sweet R
    J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.
    Sharon J; Gefter ML; Wysocki LJ; Margolies MN
    J Immunol; 1989 Jan; 142(2):596-601. PubMed ID: 2911012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of avidity and fine specificity of anti-levan antibodies.
    Brorson K; Thompson C; Wei G; Krasnokutsky M; Stein KE
    J Immunol; 1999 Dec; 163(12):6694-701. PubMed ID: 10586066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity.
    Pewzner-Jung Y; Simon T; Eilat D
    J Immunol; 1996 Apr; 156(8):3065-73. PubMed ID: 8609430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
    J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme.
    England P; Nageotte R; Renard M; Page AL; Bedouelle H
    J Immunol; 1999 Feb; 162(4):2129-36. PubMed ID: 9973487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of antibody responses against pneumococcal surface protein A: evidence for diverse DH-less heavy chain gene usage and avidity maturation.
    Rohatgi S; Dutta D; Tahir S; Sehgal D
    J Immunol; 2009 May; 182(9):5570-85. PubMed ID: 19380805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
    Cleary J; Glick GD
    Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the affinity and the fine specificity of an anti-cortisol antibody by parsimonious mutagenesis and phage display.
    Chames P; Coulon S; Baty D
    J Immunol; 1998 Nov; 161(10):5421-9. PubMed ID: 9820517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
    Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
    J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.